Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study (Q35009734)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study |
scientific article |
Statements
1 reference
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study (English)
1 reference
T Zuberbier
1 reference
A Oanta
1 reference
E Bogacka
1 reference
I Medina
1 reference
F Wesel
1 reference
P Uhl
1 reference
I Antépara
1 reference
I Jáuregui
1 reference
R Valiente
1 reference
Bilastine International Working Group
1 reference
23 October 2009
1 reference
1 reference
65
1 reference
4
1 reference
516-528
1 reference
Identifiers
1 reference
1 reference